This site is intended for healthcare professionals only
LoginRegister
WHO Alert Spurs Indias Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament InformedWHO Alert Spurs India's Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited,...
CDSCO Panel Seeks Protocol Revisions in Levim Lifetechs Teriparatide Biosimilar StudyCDSCO Panel Seeks Protocol Revisions in Levim Lifetech's Teriparatide Biosimilar Study
Drug, Vaccine Lab Tests May Cost Up to Rs 45,000 with 5% Annual HikeSame Brand Name Used for Multiple Drugs: Govt Panel Calls for Stakeholder Consultation
Rs 587 Cr Medical Devices Unit Proposed at Noida Park, BNCT Cancer Therapy Manufacturing PlannedOver 4000 medical device manufacturing sites licensed since 2021, Minister tells Parliament
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesProduct basket under Pradhan Mantri Bhartiya Janaushadhi Yojna has 2110 medicines: Minister
Biopharma SHAKTI Gets Industry Backing as Budget 2026 Pushes India’s ₹10,000 Crore Biopharma AmbitionBiocon to make Biocon Biologics a wholly owned arm
Senores PharmaSenores Pharma gets Philippine FDA approval for basket of 10 products
Biopharma SHAKTI Gets Industry Backing as Budget 2026 Pushes India’s ₹10,000 Crore Biopharma AmbitionBiocon Pharma gains tentative USFDA nod for Parkinson's disease capsules
ITAT Delhi Grants Relief to Pharmacy Owner, Deletes Rs 19.68 Lakh Addition on Demonetisation-Era SalesHaryana Pharmacy Council to Deregister Pharmacists Over Illegal Sale of Psychotropic Drugs, MTP Kits
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceSemaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to...
Ipca Pharma incorporates new wholly owned arm in Federal Republic of GermanyIpca Labs receives 3 USFDA observations for Tarapur facility
Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone LymphomaBristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma
X